Detalhe da pesquisa
1.
High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia.
Int J Equity Health
; 23(1): 84, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689295
2.
Diabetes mellitus and the progression of non-alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study.
Med J Aust
; 219(8): 358-365, 2023 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37749902
3.
Improving palliative and supportive care in advanced cirrhosis: the HepatoCare model of integrated collaborative care.
Intern Med J
; 53(11): 1963-1971, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37812158
4.
High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence.
Am J Gastroenterol
; 116(9): 1896-1904, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34465693
5.
Management, outcomes and survival of an Australian IgG4-SC cohort: The MOSAIC study.
Liver Int
; 41(12): 2934-2943, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34392596
6.
Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis.
Intern Med J
; 51(5): 691-698, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32096890
7.
Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma.
Int J Mol Sci
; 20(4)2019 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30781550
8.
Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.
Clin Gastroenterol Hepatol
; 16(2): 268-277, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29050991
9.
Exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia.
Intern Med J
; 47(4): 429-435, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28145084
10.
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.
J Hepatol
; 64(1): 19-28, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26321288
11.
The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease.
Hepatology
; 59(4): 1393-405, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24254368
12.
Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.
Int J Mol Sci
; 15(5): 8591-638, 2014 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24830559
13.
Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways.
Liver Int
; 33(4): 624-32, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23356584
14.
Use of standardised assessment forms in referrals to hepatology outpatient services: implications for accurate triaging of patients with chronic hepatitis C.
Aust Health Rev
; 37(2): 218-22, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23448666
15.
Changing Prevalence of Medication Use in People with Cirrhosis: A Retrospective Cohort Study Using Pharmaceutical Benefits Scheme Data.
Drugs Real World Outcomes
; 10(4): 605-618, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37828144
16.
Triage of referrals to outpatient hepatology services: an ineffective tool to prioritise patients?
Aust Health Rev
; 36(4): 443-7, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23062780
17.
The Patient's Perspective in Cirrhosis: Unmet Supportive Care Needs Differ by Disease Severity, Etiology, and Age.
Hepatol Commun
; 5(5): 891-905, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34027276
18.
Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis.
Sci Rep
; 11(1): 14654, 2021 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34282177
19.
Assessment of health-related quality of life and health utilities in Australian patients with cirrhosis.
JGH Open
; 5(1): 133-142, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33490623
20.
Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC).
Patient Prefer Adherence
; 14: 599-611, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32256051